Skip to content
Open access · CC-BY via OpenAlex

Epigenetic age acceleration as a biomarker for impaired cognitive abilities in adulthood following early life adversity and psychiatric disorders

John Michael Felt, Natan Yusupov, Karra Harrington, Julia Fietz, Zhenyu Z. Zhang, Martin J. Sliwinski, Nilám Ram, Kieran J. O’Donnell, Michael Joseph Meaney, Frank W. Putnam, Jennie G. Noll, Elisabeth B. Binder, Chad E. Shenk

Neurobiology of Stress · 2023 · ▲ 7 citations

Abstract

Early life adversity and psychiatric disorders are associated with earlier declines in neurocognitive abilities during adulthood. These declines may be preceded by changes in biological aging, specifically epigenetic age acceleration, providing an opportunity to uncover genome-wide biomarkers that identify individuals most likely to benefit from early screening and prevention. Five unique epigenetic age acceleration clocks derived from peripheral blood were examined in relation to latent variables of general and speeded cognitive abilities across two independent cohorts: 1) the Female Growth and Development Study (FGDS; n = 86), a 30-year prospective cohort study of substantiated child sexual abuse and non-abused controls, and 2) the Biological Classification of Mental Disorders study (BeCOME; n = 313), an adult community cohort established based on psychiatric disorders. A faster pace of biological aging (DunedinPoAm) was associated with lower general cognitive abilities in both cohorts and slower speeded abilities in the BeCOME cohort. Acceleration in the Horvath clock was significantly associated with slower speeded abilities in the BeCOME cohort but not the FGDS. Acceleration in the Hannum clock and the GrimAge clock were not significantly associated with either cognitive ability. Accelerated PhenoAge was associated with slower speeded abilities in the FGDS but not the BeCOME cohort. The present results suggest that epigenetic age acceleration has the potential to serve as a biomarker for neurocognitive decline in adults with a history of early life adversity or psychiatric disorders. Estimates of epigenetic aging may identify adults at risk of cognitive decline that could benefit from early neurocognitive screening.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.ynstr.2023.100577
Canonical
link ↗
Fetched
2026-10-16 MST

Cite this

APA
Felt, J.M., Yusupov, N., Harrington, K., Fietz, J., Zhang, Z.Z., Sliwinski, M.J., Ram, N., O’Donnell, K.J., Meaney, M.J., Putnam, F.W., Noll, J.G., Binder, E.B., &amp; Shenk, C.E. (2023). Epigenetic age acceleration as a biomarker for impaired cognitive abilities in adulthood following early life adversity and psychiatric disorders. <em>Neurobiology of Stress</em>. https://doi.org/10.1016/j.ynstr.2023.100577
Vancouver
Felt JM, Yusupov N, Harrington K, Fietz J, Zhang ZZ, Sliwinski MJ, et al. Epigenetic age acceleration as a biomarker for impaired cognitive abilities in adulthood following early life adversity and psychiatric disorders. Neurobiology of Stress. 2023. doi:10.1016/j.ynstr.2023.100577.
BibTeX
@article{john2023Epigen, title = {Epigenetic age acceleration as a biomarker for impaired cognitive abilities in adulthood following early life adversity and psychiatric disorders}, author = {John Michael Felt and Natan Yusupov and Karra Harrington and Julia Fietz and Zhenyu Z. Zhang and Martin J. Sliwinski and Nilám Ram and Kieran J. O’Donnell and Michael Joseph Meaney and Frank W. Putnam and Jennie G. Noll and Elisabeth B. Binder and Chad E. Shenk}, journal = {Neurobiology of Stress}, year = {2023}, doi = {10.1016/j.ynstr.2023.100577}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings